BLTE Competitors & Alternatives
Compare Belite Bio Inc ADR with similar stocks in the same industry
Biotechnology
BLTE
Main Stock$148.95
Tradestie Score
62
Market Cap
$2.41B
Analyst Upside
+41.3%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CYTK
Cytokinetics Inc.
|
$82.76
|
$6.68B | - | 62 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$110.00
|
$6.64B | - | 65 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$95.74
|
$6.38B | - | 54 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$29.96
|
$6.03B | - | 52 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$55.14
|
$6.02B | - | 59 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.51
|
$5.95B | - | 60 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$245.66
|
$5.92B | - | 59 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$55.03
|
$5.80B | 19.0 | 57 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$349.34
|
$5.20B | 46.2 | 60 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$54.17
|
$4.94B | - | 60 | Compare |
More BLTE Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry